Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rizatriptan for acute migraine headaches in adults.

Literature DB >> 25408622

Rizatriptan for acute migraine headaches in adults.

Rebecca Ling¹, Sheena Derry¹, R Andrew Moore¹, Henry J McQuay¹, Philip J Wiffen².

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of rizatriptan compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Entities: CellLine Chemical Disease Gene Species

Year: 2010 PMID： 25408622 PMCID： PMC4233121 DOI： 10.1002/14651858.CD008491

Source DB: PubMed Journal: Cochrane Database Syst Rev ISSN： 1361-6137

27 in total

1. Impact of covert duplicate publication on meta-analysis: a case study.

Authors: M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal: BMJ Date: 1997-09-13

Review 2. Ten years of rizatriptan: from development to clinical science and future directions.

Authors: Richard J Hargreaves; Chris R Lines; Alan M Rapoport; Tony W Ho; Fred D Sheftell
Journal: Headache Date: 2009-02 Impact factor: 5.887

Review 3. Burden of migraine. A review of its socioeconomic impact.

Authors: G D Solomon; K L Price
Journal: Pharmacoeconomics Date: 1997 Impact factor: 4.981

4. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

Authors: J H Lofland; N E Johnson; A S Batenhorst; D B Nash
Journal: Arch Intern Med Date: 1999-04-26

5. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

Authors: Seymour Diamond; Marcelo E Bigal; Stephen Silberstein; Elizabeth Loder; Michael Reed; Richard B Lipton
Journal: Headache Date: 2007-03 Impact factor: 5.887

Review 1. Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect.

Authors: Peer Tfelt-Hansen; Karl Messlinger
Journal: Br J Clin Pharmacol Date: 2019-09-04 Impact factor: 4.335

1 in total

Rizatriptan for acute migraine headaches in adults.

1. Impact of covert duplicate publication on meta-analysis: a case study.

Review 2. Ten years of rizatriptan: from development to clinical science and future directions.

Review 3. Burden of migraine. A review of its socioeconomic impact.

4. Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

5. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

6. The number needed to treat: a clinically useful measure of treatment effect.

7. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

8. Prevalence and burden of headache and migraine in Germany.

9. Improvements in health-related quality of life with sumatriptan treatment for migraine.

10. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Review 1. Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect.